Skip to content

13F-HR filed by PURA VIDA INVESTMENTS, LLC

PURA VIDA INVESTMENTS, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 68 holding rows worth $251,860,000.

Accession
0001493152-17-009084
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 69 entries on the cover page, a total value of $251,860,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $251,860,000 with VALUE read as thousands by filing date, 13F file number 028-16667. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ENVISION HEALTHCARE CORP29414D100COM187,200$11,732,000thousands by filing date
Boston Scientific Corporation101137107COM420,546$11,658,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM174,700$11,153,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM88,112$10,721,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW65,000$10,019,000thousands by filing date
LIVANOVA PLCG5509L101SHS140,002$8,570,000thousands by filing date
Merck & Co.,Inc.58933Y105COM130,000$8,332,000thousands by filing date
Merck & Co.,Inc.58933Y105COM130,000$8,332,000thousands by filing dateput
ICU MED INC44930G107COM45,000$7,763,000thousands by filing date
BAXTER INTL INC071813109COM125,000$7,568,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR200,000$6,818,000thousands by filing datecall
INVACARE CORP461203101COMMON STOCK505,000$6,666,000thousands by filing date
GLOBUS MED INC CL A379577208Stock200,000$6,630,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM398,206$6,586,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM70,000$6,554,000thousands by filing date
Merck & Co.,Inc.58933Y105COM100,000$6,409,000thousands by filing datecall
ATHENAHEALTH INC04685W103COMMON STOCK43,000$6,044,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK221,685$5,558,000thousands by filing date
INTERSECT ENT INC46071F103COM197,498$5,520,000thousands by filing date
PRA HEALTH SCIENCES INC69354M108COM72,500$5,438,000thousands by filing date
QIAGEN NVN72482107COMMON STOCK-FO156,900$5,261,000thousands by filing date
BIO RAD LABS INC090572207CL A22,820$5,164,000thousands by filing date
ADVISORY BOARD CO/THE00762W107Domestic Common100,000$5,150,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM5,000$4,677,000thousands by filing datecall
EXACT SCIENCES CORP COM30063P105Stock125,000$4,421,000thousands by filing date
PENUMBRA INC COM70975L107Stock50,000$4,388,000thousands by filing date
TESARO INC881569107COM29,900$4,182,000thousands by filing date
NUVASIVE INC670704105COM50,000$3,846,000thousands by filing datecall
EDWARDS LIFESCIENCES CORP COM28176E108Stock30,000$3,547,000thousands by filing datecall
Gilead Sciences,Inc.375558103COM50,000$3,539,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM80,000$3,448,000thousands by filing date
AbbVie,Inc.00287Y109COM46,012$3,336,000thousands by filing date
AXOGEN INC05463X106COM179,369$3,004,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM30,000$2,809,000thousands by filing dateput
WRIGHT MED GROUP N VN96617118ORD SHS100,000$2,749,000thousands by filing datecall
BRUKER CORP116794108COM81,617$2,354,000thousands by filing date
IMMUNOMEDICS INC452907108COM256,800$2,268,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock265,589$2,223,000thousands by filing date
NEURODERM LTDM74231107ORD SHS70,000$2,093,000thousands by filing date
TESARO INC881569107COM13,100$1,832,000thousands by filing datecall
OTONOMY INC68906L105COM96,800$1,825,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS150,000$1,781,000thousands by filing date
Viewra, Inc92672L107COM260,670$1,687,000thousands by filing date
EPIZYME INC29428V104COM100,000$1,510,000thousands by filing date
VIVEVE MED INC92852W204COM NEW200,132$1,437,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM79,103$1,384,000thousands by filing date
STEADYMED LTDM84920103SHS215,214$1,356,000thousands by filing date
SYNERGY PHARMACEUTICALS DEL871639308COM NEW267,800$1,192,000thousands by filing datecall
SAVARA INC805111101COM200,000$1,176,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock150,000$1,125,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM150,000$1,095,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM30,000$1,011,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM15,000$958,000thousands by filing datecall
WRIGHT MED GROUP N VN96617126RIGHT 03/01/2019587,241$857,000thousands by filing date
AGENUS INC00847G705COM NEW200,000$782,000thousands by filing datecall
AGILE THERAPEUTICS INC00847L100COM174,501$654,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW35,000$590,000thousands by filing date
REGENXBIO INC75901B107COM28,820$569,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock100,000$556,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM60,000$552,000thousands by filing date
Alliqua BioMedical Inc019621200COM NEW1,208,026$447,000thousands by filing date
ADVISORY BOARD CO/THE00762W107Domestic Common4,400$227,000thousands by filing datecall
AVEO PHARMACEUTICALS INC053588109COM100,000$222,000thousands by filing date
DIFFUSION PHARMACEUTICALS IN253748206COM NEW82,816$193,000thousands by filing date
INTERSECT ENT INC46071F103COM4,500$126,000thousands by filing datecall
FOAMIX PHARMACEUTICALS LTDM46135105SHS24,100$112,000thousands by filing date
ACCURAY INC DEL004397105COM10,500$50,000thousands by filing datecall
Ocugen43358V109Common13,526$24,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-17-009084this filing2017-08-14acceptance time not in the bulk data set